150 related articles for article (PubMed ID: 35185921)
1. Hyper IgE Syndrome in an Isolated Population in Israel.
Lachover-Roth I; Lagovsky I; Shtorch-Asor A; Confino-Cohen R; Reinstein E; Garty BZ
Front Immunol; 2022; 13():829239. PubMed ID: 35185921
[TBL] [Abstract][Full Text] [Related]
2. ZNF341 controls STAT3 expression and thereby immunocompetence.
Frey-Jakobs S; Hartberger JM; Fliegauf M; Bossen C; Wehmeyer ML; Neubauer JC; Bulashevska A; Proietti M; Fröbel P; Nöltner C; Yang L; Rojas-Restrepo J; Langer N; Winzer S; Engelhardt KR; Glocker C; Pfeifer D; Klein A; Schäffer AA; Lagovsky I; Lachover-Roth I; Béziat V; Puel A; Casanova JL; Fleckenstein B; Weidinger S; Kilic SS; Garty BZ; Etzioni A; Grimbacher B
Sci Immunol; 2018 Jun; 3(24):. PubMed ID: 29907690
[TBL] [Abstract][Full Text] [Related]
3. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
4. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.
Béziat V; Li J; Lin JX; Ma CS; Li P; Bousfiha A; Pellier I; Zoghi S; Baris S; Keles S; Gray P; Du N; Wang Y; Zerbib Y; Lévy R; Leclercq T; About F; Lim AI; Rao G; Payne K; Pelham SJ; Avery DT; Deenick EK; Pillay B; Chou J; Guery R; Belkadi A; Guérin A; Migaud M; Rattina V; Ailal F; Benhsaien I; Bouaziz M; Habib T; Chaussabel D; Marr N; El-Benna J; Grimbacher B; Wargon O; Bustamante J; Boisson B; Müller-Fleckenstein I; Fleckenstein B; Chandesris MO; Titeux M; Fraitag S; Alyanakian MA; Leruez-Ville M; Picard C; Meyts I; Di Santo JP; Hovnanian A; Somer A; Ozen A; Rezaei N; Chatila TA; Abel L; Leonard WJ; Tangye SG; Puel A; Casanova JL
Sci Immunol; 2018 Jun; 3(24):. PubMed ID: 29907691
[TBL] [Abstract][Full Text] [Related]
5. Inherited human ZNF341 deficiency.
Béziat V; Fieschi C; Momenilandi M; Migaud M; Belaid B; Djidjik R; Puel A
Curr Opin Immunol; 2023 Jun; 82():102326. PubMed ID: 37080116
[TBL] [Abstract][Full Text] [Related]
6. Hyper IgE Syndromes.
Gracci S; Novelli T; D'Elios S; Bernardini R; Peroni D
Curr Pediatr Rev; 2024; 20(3):253-264. PubMed ID: 37702167
[TBL] [Abstract][Full Text] [Related]
7. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
8. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
9. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience.
Joshi AY; Iyer VN; Boyce TG; Hagan JB; Park MA; Abraham RS
Allergy Asthma Proc; 2009; 30(1):23-7. PubMed ID: 19331717
[TBL] [Abstract][Full Text] [Related]
11. Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis.
Frede N; Rojas-Restrepo J; Caballero Garcia de Oteyza A; Buchta M; Hübscher K; Gámez-Díaz L; Proietti M; Saghafi S; Chavoshzadeh Z; Soler-Palacin P; Galal N; Adeli M; Aldave-Becerra JC; Al-Ddafari MS; Ardenyz Ö; Atkinson TP; Kut FB; Çelmeli F; Rees H; Kilic SS; Kirovski I; Klein C; Kobbe R; Korganow AS; Lilic D; Lunt P; Makwana N; Metin A; Özgür TT; Karakas AA; Seneviratne S; Sherkat R; Sousa AB; Unal E; Patiroglu T; Wahn V; von Bernuth H; Whiteford M; Doffinger R; Jouhadi Z; Grimbacher B
J Clin Immunol; 2021 Nov; 41(8):1804-1838. PubMed ID: 34390440
[TBL] [Abstract][Full Text] [Related]
12. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
13. Human hyper-IgE syndrome: singular or plural?
Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
[TBL] [Abstract][Full Text] [Related]
14. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
15. Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India.
Saikia B; Suri D; Goel S; Rawat A; Minz RW; Gupta A; Sharma S; Ohara O; Imai K; Nonoyama S; Sehgal S; Singh S
Asian Pac J Allergy Immunol; 2014 Dec; 32(4):321-7. PubMed ID: 25543043
[TBL] [Abstract][Full Text] [Related]
16. Hyper IgE syndromes: clinical and molecular characteristics.
Al-Shaikhly T; Ochs HD
Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
[TBL] [Abstract][Full Text] [Related]
17. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.
Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H
J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740
[TBL] [Abstract][Full Text] [Related]
18. [Hyper-IgE syndromes].
He YY; Liu B; Xiao XP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
[TBL] [Abstract][Full Text] [Related]
19. The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation.
Broides A; Mandola AB; Levy J; Yerushalmi B; Pinsk V; Eldan M; Shubinsky G; Hadad N; Levy R; Nahum A; Ben-Harosh M; Lev A; Simon A; Somech R
Immunol Res; 2017 Jun; 65(3):651-657. PubMed ID: 28070732
[TBL] [Abstract][Full Text] [Related]
20. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
